SCHEMBL28317880

SCHEMBL28317880

O=C(O)C1=CC=C2N=CN=C2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28321164 0.98 LMNA (0.31)
SCHEMBL29103538 0.76 TP53 (0.30)
SCHEMBL133569 0.70
SCHEMBL1759161 0.70
SCHEMBL13140760 0.70 TSHR (0.39)
Ammonia Solution, Strong SCHEMBL6052085 0.69
SCHEMBL16618909 0.65
SCHEMBL17204228 0.65
SCHEMBL3914975 0.64 TSHR (0.33)
SCHEMBL14594120 0.64 TSHR (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250109148-A1 HETEROCYCLIC GLP-1 AGONISTS SHANGHAI SHOUTI BIOTECHNOLOGY CO., LTD. (CN) 2025-04-03 US disclosed
WO-2023245137-A1 SLOW SKELETAL TROPONIN ACTIVATORS CYTOKINETICS, INCORPORATED (US) 2023-12-21 WO disclosed
EP-4271674-A1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2023-11-08 EP disclosed
WO-2022225914-A1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2022-10-27 WO disclosed
CN-110114351-A The heterocycle inhibitor of MCT4 维托尔股份有限公司 2019-08-09 CN disclosed